Compare GDDY & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDDY | HOLX |
|---|---|---|
| Founded | 1997 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 16.9B |
| IPO Year | 2014 | 1995 |
| Metric | GDDY | HOLX |
|---|---|---|
| Price | $91.75 | $76.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 13 |
| Target Price | ★ $136.44 | $77.89 |
| AVG Volume (30 Days) | 1.9M | ★ 95.4M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.60 | 0.79 |
| Revenue | N/A | ★ $4,100,500,000.00 |
| Revenue This Year | $7.94 | $4.74 |
| Revenue Next Year | $6.10 | $5.03 |
| P/E Ratio | ★ $57.68 | $96.23 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $73.06 | $53.62 |
| 52 Week High | $184.71 | $76.07 |
| Indicator | GDDY | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 59.54 | 69.09 |
| Support Level | $80.58 | $75.10 |
| Resistance Level | $92.65 | N/A |
| Average True Range (ATR) | 4.15 | 0.19 |
| MACD | 0.48 | 0.03 |
| Stochastic Oscillator | 80.45 | 95.19 |
GoDaddy Inc provides digital solutions and services for entrepreneurs, small businesses, individuals, organizations, developers, designers, and domain investors. It offers tools intended to support business creation and management through an integrated service platform. The company operates through two segments: Applications and Commerce (A&C) and Core Platform (Core). The majority of the company's revenue is derived from the Core Platform segment, which consists of sales of domain registrations and renewals, aftermarket domain sales, website hosting products and website security products. Geographically, it generates the maximum revenue from the United States.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.